醫療新知

快、準、省！INR現場快篩提升抗凝治療新效率

Posted on by Wine-Font
22
4 月

本翻譯僅作學術交流用，無商業意圖，請勿轉載，如有疑議問請來信

INR 醫療現場檢測（POCT）與實驗室檢測在準確性與臨床決策一致性上表現相當，能縮短就診時間、即時調整劑量、減少併發症與急診次數，提升病人滿意度並降低整體醫療成本。

Point of care INR testing

醫療現場 INR 測試

https://diagnostics.roche.com/global/en/article-listing/the-benefits-of-point-of-care-testing.html

醫療現場測試的好處
The benefits of point of care testing

醫療現場測試（POCT）在 INR 測量的精確度 1-3 和準確性 3-6 方面與實驗室測試相當，並且在 VKA 劑量決策中的臨床一致性 3,6,7 。

Point of care testing (POCT), is comparable to laboratory testing for INR measurements with regards to the precision1-3 and accuracy3-6 of results and the clinical agreement in the VKA-dosing decision. 3,6,7

CoaguChek 系統提供了一個全面的解決方案，可以幫助您改善護理質量、病人滿意度和工作流程效率。

CoaguChek systems offer a holistic solution that can help you improve quality of care, patient satisfaction and workflow efficiency.

精簡您的工作流程
Streamline your workflow

POCT 可以精簡抗凝治療管理，並通過提供以下方式提高工作流程效率：
POCT can streamline anticoagulation management and improve workflow efficiency over usual care by providing: 

  • 更短的診所訪問 13-15
    Shorter clinic visits13-15
  • 減少工作負擔 9,14   Reduced workload9,14
  • 更快的臨床決策，包括即時現場劑量調整 9,14,16,17
    Faster clinical decisions including immediate on-the-spot dose adjustment9,14,16,17

改善病人護理和滿意度
Improve patient care and satisfaction

使用 POCT 管理的病人相比於接受常規護理的病人，達到治療範圍的時間更長，且超出範圍的數值更少。 18-20
Patients managed with POCT achieve a higher time in therapeutic range and fewer values out of range compared with patients treated with usual care.18-20

這導致了：  This results in:

  • 減少與治療相關的併發症 9,21
    Fewer treatment-related complications9,21
  • 減少住院和急診部就診 9,21
    Fewer hospitalizations and emergency department visits9,21
  • 提高病人滿意度 13,22,23
    Improved patient satisfaction13,22,23

增加收入並降低成本
Increase revenue and cut costs

經濟評估顯示，POCT 是一種成本效益高的替代方案 24,25 ，並且與以下因素相關：
Economic evaluations have shown that POCT is a cost-effective alternative to usual care24,25 and is associated with:

  • 降低診所運營成本 14,22
    Reduced clinic running costs14,22
  • 在某些環境中增加收入生成 9
    Increased revenue generation in some settings9
  • 由於住院和急診部就診次數減少而節省的成本 9,10
    Cost savings due to fewer hospitalizations and emergency department visits9,10
  • 減少醫療系統成本的潛力 24-26
    The potential to reduce costs for the healthcare system24-26

參考文獻 References

  1. Bonar 等人 (2015)。血栓與止血學期刊 41, 279–286
    Bonar et al. (2015). Semin Thromb Hemost 41, 279–286
  2. Plesch 等人 (2008)。血栓研究 123, 381–389。
    Plesch et al. (2008). Thromb Res 123, 381–389.
  3. Christensen 等人 (2012)。血栓與止血學期刊 10, 251–60
    Christensen et al. (2012). J Thromb Haemost 10, 251–60 
  4. Meneghelo 等人 (2015)。國際實驗室血液學期刊 37, 536–543
    Meneghelo et al. (2015). Int J Lab Hematol 37, 536–543
  5. Plesch 等人 (2009)。國際實驗室血液學雜誌 31, 20–5
    Plesch et al. (2009). Int J Lab Hematol 31, 20–5 
  6. Dillinger 等人 (2016)。血栓研究 140, 66–72
    Dillinger et al. (2016). Thromb Res 140, 66–72
  7. Colella 等人 (2012)。血液凝固與纖維蛋白溶解 23, 172–174
    Colella et al. (2012). Blood Coagul Fibrinolysis 23, 172–174
  8. Larsson 等人 (2015)。烏普薩拉醫學科學雜誌 120, 1–10
    Larsson et al. (2015). Ups J Med Sci 120, 1–10
  9. Wurster & Doran. (2006). Dis Manag 9, 201–209
  10. Rudd & Dier. (2010). Pharmacotherapy 30, 330–338
  11. Shaw et al. (2014). Int J Pharm Pract 22, 397–406
  12. Gubala et al. (2012). Anal Chem 84, 487–515
  13. Kong 等人 (2008)。血液學年鑑 87, 905–910
    Kong et al. (2008). Ann Hematol 87, 905–910
  14. Fernholm & Hermansson (2015)。BMJ 質量改善報告 4, pii: u208905.w3692
    Fernholm & Hermansson. (2015). BMJ Qual Improv Rep 4, pii: u208905.w3692
  15. Kasinathan 等人 (2016)。OALib 期刊 3, e242281
    Kasinathan et al. (2016). OALib J 3, e242281
  16. Smith 等人 (2012)。美國醫學科學雜誌 344, 289–293
    Smith et al. (2012). Am J Med Sci 344, 289–293
  17. Richter 等人 (2016)。藥學年鑑 50, 645–648
    Richter et al. (2016). Ann Pharmacother 50, 645–648
  18. Harrison 等人 (2015)。國際藥學實踐雜誌 23, 173-181
    Harrison et al. (2015). Int J Pharm Pract 23, 173-181
  19. Okuyama 等人 (2014)。心臟雜誌 78, 1342–1348
    Okuyama et al. (2014). Circ J 78, 1342–1348
  20. Mearns 等人 (2014)。血栓學雜誌 12, 14
    Mearns et al. (2014). Thromb J 12, 14
  21. Karlsson (2016)。BMJ 質量改善報告 5, pii: u211003.w4421
    Karlsson (2016). BMJ Qual Improv Rep 5, pii: u211003.w4421
  22. Chan 等人 (2006)。英國臨床藥理學雜誌 62, 601–609
    Chan et al. (2006). Br J Clin Pharmacol 62, 601–609
  23. Thompson 等人 (2009)。藥學實踐 (格拉納達) 7, 213–217
    Thompson et al. (2009). Pharm Pract (Granada) 7, 213–217
  24. 健康質量安大略省 (2009)。安大略健康技術評估系列 9, 1–114
    Health Quality Ontario. (2009). Ont Health Technol Assess Ser 9, 1–114
  25. Claes 等人 (2006)。價值健康 9, 369–376
    Claes et al. (2006). Value Health 9, 369–376  
  26. Gerkens 等人 (2012)。血栓與溶栓雜誌 34, 300–309
    Gerkens et al. (2012). J Thromb Thrombolysis 34, 300–309
Wine-Font